SCHEMBL8096793

SCHEMBL8096793

Nc1nc2c(c3nc(-c4ccccc4)cn13)CCCC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
KDM4E B2RXH2 5/20 0.45
MAPT P10636 3/20 0.45
PKM P14618 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 1/20 0.45
MITF O75030 1/20 0.45
ADORA2A P29274 2/20 0.44
ADORA1 P30542 1/20 0.44
NTRK1 P04629 1/20 0.43
IGF1R P08069 1/20 0.43
FGFR1 P11362 1/20 0.43
LTK P29376 1/20 0.43
MAP2K2 P36507 1/20 0.43
MAPK9 P45984 1/20 0.43
RPS6KA3 P51812 1/20 0.43
PRKX P51817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8102864 0.83 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL8886770 0.82 GABRA3 (0.43) ACHE
SCHEMBL8103377 0.80 KDM4E (0.45) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL8097140 0.80 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL8088074 0.77 KDM4E (0.40) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL8094932 0.73 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTPKMNPC1
SCHEMBL8094714 0.70 GABRA2 (0.64) CLK4
SCHEMBL8097295 0.68 GABRA3 (0.44)
SCHEMBL21963403 0.67 ACHE (0.53) ALDH1A1KDM4ESMN1; SMN2ADORA2AADORA1
SCHEMBL30162274 0.67 ACHE (0.53) ALDH1A1KDM4ESMN1; SMN2ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013799-A HIGHLY SELECTIVE AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR G-AMINOBUTYRIC ACID (GABA) BRAIN RECEPTORS; USEFUL IN DIAGNOSIS/TREATMENT OF ANXIETY, SLEEP, AND SEIZURE DISORDERS, DRUG OVERDOSE, AND ALERTNESS ENHANCEMENT ALERTNESS NEUROGEN CORPORATION (US) 2000-01-11 US disclosed